{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibdc6osff6k2v6p7ardf6jbsq6vykaf4e3fonof2zdpkjrpcdzd34",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3metkvnicqu22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibecu6zn7swbobck4z5sj3a67tcundbvwvi5um2he5pmkhc4idarm"
    },
    "mimeType": "image/jpeg",
    "size": 570949
  },
  "path": "/news/2026-02-combining-glp-drugs-hormones-uterine.html",
  "publishedAt": "2026-02-14T11:00:06.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "Adding GLP-1 medications like Ozempic to progestin therapy could cut the risk of developing endometrial cancer. A retrospective study published in the journal JAMA Network Open found that women using this combination had a much lower risk of developing the disease than those on progestins alone.",
  "title": "Combining GLP-1 drugs with hormones may lower uterine cancer risk"
}